Signal AI diagnostics lift sensitivity from 72% to 80%; drug discovery success from 10% to 70%

Summary

This signal shows AI measurably raising the performance of medical professionals and researchers. EY treats AI that enhances rather than replaces cognition as the most immediate form of human augmentation. Clinicians working with AI-assisted diagnostics see sensitivity climb from 72% to 80%, while the time needed for a diagnosis falls by 30% and accuracy improves. The gains in pharmaceutical research are even larger. When AI-led research is paired with robotic laboratory systems, discovery timelines shrink sharply and success rates reach 70%, compared with 10% under traditional methods. EY presents these results as evidence that pairing human expertise with machine analysis already delivers tangible outcomes.